2,729 reports of this reaction
1.5% of all ACYCLOVIR reports
#19 most reported adverse reaction
FEBRILE NEUTROPENIA is the #19 most commonly reported adverse reaction for ACYCLOVIR, manufactured by Bausch Health US, LLC. There are 2,729 FDA adverse event reports linking ACYCLOVIR to FEBRILE NEUTROPENIA. This represents approximately 1.5% of all 186,079 adverse event reports for this drug.
Patients taking ACYCLOVIR who experience febrile neutropenia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FEBRILE NEUTROPENIA is a less commonly reported adverse event for ACYCLOVIR, but still significant enough to appear in the safety profile.
In addition to febrile neutropenia, the following adverse reactions have been reported for ACYCLOVIR:
The following drugs have also been linked to febrile neutropenia in FDA adverse event reports:
FEBRILE NEUTROPENIA has been reported as an adverse event in 2,729 FDA reports for ACYCLOVIR. This does not prove causation, but indicates an association observed in post-market surveillance data.
FEBRILE NEUTROPENIA accounts for approximately 1.5% of all adverse event reports for ACYCLOVIR, making it a notable side effect.
If you experience febrile neutropenia while taking ACYCLOVIR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.